ArticleClinical and experimental medicine2018

High mTOR expression independently prognosticates poor clinical outcome to induction chemotherapy in acute lymphoblastic leukemia.

Asheema Khanna et al.PubMed ↗Publisher ↗

No numbers read from the abstract.